Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study

Introduction: Biomarkers that will reliably predict the onset of Alzheimer’s disease (AD) are urgently needed. Although cerebrospinal fluid (CSF) amyloid beta 1–42 (Aβ42), total tau, and phosphorylated tau can be used to complement the clinical diagnosis of AD, amnestic mild cognitive impairment (aM...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauridsen, Camilla, Sando, Sigrid B., Shabnam, Adiba, Møller, Ina, Berge, Guro, Grøntvedt, Gøril R., Bakken, Inger J., Salvesen, Øyvind, Bråthen, Geir, White, Linda R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772322/
https://www.ncbi.nlm.nih.gov/pubmed/26973507
http://dx.doi.org/10.3389/fnagi.2016.00030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772322/
https://www.ncbi.nlm.nih.gov/pubmed/26973507
http://dx.doi.org/10.3389/fnagi.2016.00030

Ejemplares similares